KYLEIGH HART: Open Payments
NPI 1760085195 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$611 in 26 payments from 14 companies in 2025. Trend: 2023 $1,056 · 2024 $1,543 · 2025 $611
Food & beverage: $611
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $113 |
| ABBVIE INC. | 4 | $100 |
| Lilly USA, LLC | 2 | $59 |
| E.R. Squibb & Sons, L.L.C. | 2 | $56 |
| Amgen Inc. | 3 | $56 |
| Novartis Pharmaceuticals Corporation | 2 | $49 |
| UCB, Inc. | 2 | $41 |
| Gilead Sciences, Inc. | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Genentech USA, Inc. | 1 | $20 |
Products named: TALTZ, TREMFYA, ORENCIA, SIMPONI ARIA, SKYRIZI, COSENTYX, Bimzelx, VENCLEXTA.
Industry payments across FL — which companies pay providers there.
